Filip Miljkovic

Orcid: 0000-0001-5365-505X

According to our database1, Filip Miljkovic authored at least 13 papers between 2019 and 2024.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2024
Active Learning Approach for Guiding Site-of-Metabolism Measurement and Annotation.
J. Chem. Inf. Model., 2024

2023
Protein kinase inhibitors.
Dataset, May, 2023

Interpretable bilinear attention network with domain adaptation improves drug-target prediction.
Nat. Mac. Intell., February, 2023

2022
Candidate compounds from the design of covalent Bruton's tyrosine kinase (BTK) inhibitors via focused deep generative modeling.
Dataset, January, 2022

Multi-task convolutional neural networks for predicting in vitro clearance endpoints from molecular images.
J. Comput. Aided Mol. Des., 2022

2021
Hierarchical Clustering Split for Low-Bias Evaluation of Drug-Target Interaction Prediction.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2021

2020
Assessing the information content of structural and protein-ligand interaction representations for the classification of kinase inhibitor binding modes via machine learning and active learning.
J. Cheminformatics, 2020

Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
J. Comput. Aided Mol. Des., 2020

2019
Promiscuous compounds with activity against different target classes.
Dataset, November, 2019

Machine Learning Models for Predicting Kinase Inhibitors with Different Binding Modes.
Dataset, August, 2019

Machine Learning Models for Predicting Kinase Inhibitors with Different Binding Modes.
Dataset, August, 2019

Promiscuity cliffs (PCs), promiscuity cliff pathways (PCPs), and promiscuity hubs (PHs) formed by inhibitors of human kinases.
Dataset, March, 2019

Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
J. Comput. Aided Mol. Des., 2019


  Loading...